In this article, we will take a detailed look at 10 stocks with at least $20 million in insider spending recently.
Assembly Biosciences (ASMB) announced positive interim Phase 1a results in healthy participants from its ongoing Phase 1a/b study of ABI-1179, ...
Among Assembly Biosciences’ leading candidates is ABI-5366, a long-acting herpes simplex virus helicase-primase inhibitor, which is in Phase 1a/1b clinical trial to treat recurrent genital ...
Assembly Biosciences, Inc. (NASDAQ:ASMB – Get Free Report) was the target of a significant growth in short interest in February. As of February 15th, there was short interest totalling 17,200 shares, ...
Hosted on MSN23d
Assembly Biosciences and Gilead's genital herpes treatment gives positive results in early stage trialAssembly Biosciences (ASMB) announced promising interim results from its ongoing Phase 1a/b study of ABI-1179, an investigational drug which is a long-acting helicase-primase inhibitor for ...
Department of Biology, Tufts University, Medford, Massachusetts 02130, United States ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results